=====================
MCTC Holdings, Inc. (MCTC)
Alert Price: $0.4350
Float: 3.5M
Chart Analysis
Website | Recent News
========================
Members,
it's time for you to get MCTC on your radar.
This low float CBD alert appears ready to breakout on some bullish news that was just released to the public.
MCTC Announces Hemp Extract-Based Alcohol Replacement Technology Test Results: Cannabinoid Levels Undetectable
A few hours ago the Company provided information concerning new test results for its Hemp You Can Feel™ technology, a revolutionary hemp-based infusion designed as a replacement for alcohol in many beverages.
“Our new test results for our Hemp You Can Feel™ infusion technology are very impressive, exceeding even our optimistic expectations,” commented CEO Arman Tabatabaei. “While Hemp You Can Feel™ is based on hemp extracts, certified independent laboratory testing utilizing high-performance liquid chromatography (HPLC) indicated undetectable levels of all hemp extracts and major cannabinoids and an absence of other compounds. We believe the uses for this advanced infusion technology are many, especially as a replacement for alcohol in various beverages.”
The Company recently introduced Hemp You Can Feel™, an infusion technology that provides unparalleled relaxation while allowing the consumer to avoid the negative health effects of alcohol consumption. The technology is based on a manufacturing process that is all natural and relies on no chemical surfactants, stabilizers or additives in order to produce an infusion technology with virtually no detectable taste and excellent food and beverage integration characteristics.
The Company is today announcing separate test results on three new infusions, including the Hemp You Can Feel™ technology in powder form, in a liquid concentrate form and in a premixed nonalcoholic cocktail formulation. In industry standard HPLC-based potency testing conducted by licensed independent laboratories, hemp extract and cannabinoid levels were undetectable for all three preparations. More extensive analysis designed to indicate other similar compounds showed zero presence.
MCTC plans to use this technology as the basis for products it plans to introduce over the coming months. Additionally, the Company plans to license the technology and “white label” manufacture products in its licensed Los Angeles facility, as appropriate.
While additional testing will be required, the Company also believes this unique infusion technology could prove useful as an ultra-low-level cannabidiol (CBD) delivery system for foods and beverages.
Mr. Tabatabaei continued, “Our next step is to create microparticles and nanoparticles of Hemp You Can Feel™ utilizing our patent-pending particle creation process. We think these new microparticle and nanoparticle technologies could prove very useful for advanced food and beverage infusion. We believe this additional area of research is especially topical considering the recent warnings put forth by the U.S. Food and Drug Administration concerning the use of CBD in foods and beverages.”
The Company has recently filed four patents on hemp extract technologies and delivery systems. MCTC is currently working with its patent counsel to protect various aspects of this new technology. Additionally, as previously announced, the Company plans to continue in other areas of delivery systems research, including its programs pertaining to polymeric nanoparticles and nanofibers. The version of Hemp You Can Feel™ being discussed in this release is non-nanoparticle based.
We think the Street is going to react positively to this news, and those who grab up shares early could be handsomely rewarded this week!
This low float alert is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
About MCTC Holdings, Inc.
MCTC Holdings, Inc. (OTC:MCTC) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp industry moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp value chain. The Company plans to actively pursue R&D programs and productization for exotic extract isolation, bioenhancement of hemp extracts and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing hemp sector. The Company is headed and managed by a group of highly experienced hemp and cannabis industry pioneers and entrepreneurs.
More information on the Company can be viewed at www.CannabisGlobalinc.com.
Cutting-Edge Technology
MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (nnw.fm/cK3Bl):
Significantly improving bioavailability
Allowing for ultra-high loading rates
Enhancing customization of cannabinoid combinations
Improved dosing precision
Providing more control in release parameters
MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.
Patents
MCTC has now filed four patents on its cannabinoid delivery technology systems:
The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.
Collaborations
MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).
Recent Developments
MCTC Announces Product Breakthrough - Hemp You Can Feel™ Infusion Technology as Replacement for Alcohol in Beverages
In late November the Comany announced a new class of hemp infusion technology designed to replace alcohol in many beverages. The infusion will be marketed under the Company's Hemp You Can Feel™ brand name and adds to MCTC's growing portfolio of intellectual property, which currently includes four patent pending technologies. As the Company has stated previously, multiple additional patent filings are expected.
"The formulations and delivery vehicles our researchers have developed are nothing short of spectacular," commented Chief Executive Officer, Arman Tabatabaei. "While the technology is based on hemp extracts, levels are many magnitudes lower than are typically seen in the marketplace. In fact, certified laboratory testing utilizing High Performance Liquid Chromatography (HPLC) certified undetectable levels of hemp extracts and cannabinoids. Simply put, we believe this is a revolutionary technology for the marketplace and a legitimate replacement for alcohol in many beverages."
Hemp You Can Feel™, which can be used as the basis for a host of beverage and food formulations provides unparalleled relaxation, while allowing the consumer to avoid the negative health effects of alcohol consumption. The Company is especially proud of the expected label, which is ultra-clean, non-GMO and 100% natural. Manufacturing occurs at room temperature to ensure all the natural enzymes present in the organic portions of the ingredients are preserved. MCTC believes Hemp You Can Feel™ creates an entirely new category of infusion technology for foods and beverages based on natural ingredients.
Hemp You Can Feel™ utilizes no chemical surfactants or stabilizers and requires no high shear processing, sonication, spray drying or other harsh extract manipulations, all of which are common legacy processing technologies. Additionally, the technology contains no artificial colors, dyes, or preservatives and most importantly, there is no detectable hemp taste. The Company is currently capable of producing Hemp You Can Feel™ at high volume in powerized form. A liquid concentrate has also been developed, which is pending final laboratory and formulation testing.
MCTC plans to use this technology as the basis for products it plans to introduce over the coming months. Additionally, the Company plans to license the technology and "white label" produce products at its Los Angeles production facility, as appropriate.
Mr. Tabatabaei continued, "One of the biggest technological challenges was stabilizing the formulation into a substrate. We were fortunate that our researchers were able to work with a major food ingredient manufacturer that provided the exact expertise and associated non-GMO technologies allowing us to complete the last piece of the research puzzle. This development was most certainly an interdisciplinary success based on extensive collaboration between our researchers and others in the food sciences industry."
The Company and its research partner have recently filed four patents on hemp extract technologies and delivery systems. MCTC is currently working with patent counsel to protect various aspects of this new technology. Additionally, as previously announced, the Company plans to continue other areas of hemp extract delivery systems research including its programs pertaining to polymeric nanoparticles and nanofibers and plans additional patent filings relative to expected developments. The technologies being announced today are non-nanoparticle based.
MCTC Expands R&D Program to Include Producing Polymeric Nanoparticles of Valuable, Hard-to-Obtain Cannabinoids
Company’s groundbreaking nanoparticle research has potential to achieve superior effects with reduced amounts of cannabinoids and may lead to new product creation, research avenues
In late November, the Company announced an expanded R&D program designed to produce polymeric nanoparticles of cannabinol (CBN). Expansion of the Company’s R&D program also includes a goal of creating nanoparticles of cannabinoid glycosides. MCTC believes such nanoparticles and nanofibers will hold significant future commercial viability.
CBN is found only in small amounts and mostly results from oxidation of the other cannabinoids in cannabis. Thus, CBN is difficult and expensive to obtain. Nanoparticles of CBN have the potential to allow formulators to use only minuscule amounts of the cannabinoid to achieve the same or superior effects attained using much larger amounts of traditionally prepared CBN. Based on MCTC’s own experience producing cannabidiol (CBD) nanoparticles and nanofibers, the Company’s research team plans to produce CBN nanoparticles with both immediate and controlled-release properties.
“We are continuing our R&D programs based on three primary goals,” commented MCTC CEO Arman Tabatabaei. “First, we plan to continue toward mass production of immediate and controlled-release CBD nanoparticles and, to a lesser extent, CBD nanofibers. Second, we plan to utilize this experience to replicate the process using some of the minor cannabinoids, with CBN selected as the first target. Lastly, we are focusing all of our research toward protecting the intellectual property we develop. Thus far, we have filed four patents, with one additional application in progress. We are likely to file several more patent applications over the coming months as our cannabinoid R&D programs progress.”
MCTC has also added the creation of nanoparticles of cannabinoid glycosides to its research program.
One of the aims of the CBN, minor cannabinoid and glycosides research program is to develop nanoparticles of these cannabinoids for inclusion in coaxial particles of other cannabinoids. For example, several studies indicate that CBN may counteract some of the negative effects of other cannabinoids; thus, the creation of coaxial particles containing both CBN and other cannabinoids, especially psychoactive cannabinoids, could lead to new avenues of research and possibility to commercially viable products.
The polymer-based nanoparticles being developed by MCTC significantly differ from the simple oil-in-water nanoemulsions being marketed as interim solutions for the food and beverage industry. The polymer-based particles the Company is developing will allow for significant loading of active ingredients and unparalleled flexibility in creating custom cannabinoid combinations with unique performance characteristics. MCTC believes polymeric nanoparticles will be an important technology area for the cannabinoid formulation marketplace. The Company plans multiple additional patent filings relative to these technologies.
Market Outlook:
Brightfield Group, a leading market and consumer intelligence firm for the legal CBD and cannabis industries, reported significant expected acceleration in growth for the CBD market, resulting in a 706% year-over-year CBD product sales jump in the US in 2019 to around $5 billion in total sales, with sales expected to reach $23.7 billion by 2023. This suggests the overall CBD-based products market is set to grow by a stunning 107% CAGR over coming years.
Zenith Global, a leading global food and drink consulting firm, projects that the US market for cannabis, CBD and Hemp infused drinks will grow to over $1.4 Billion by 2024, an almost fifteen times (15x) increase from 2018 sales of just $89 million.
According to the Marijuana Business Factbook, retail sales of medical and recreational cannabis in the United States are on pace to eclipse $12 billion by the end of this year. This would be an increase of roughly 35% over 2018.
Retail sales could rise as high as $30 billion by 2023!
It was a banner year in 2018 with investors pouring an amazing $10 billion into cannabis in North America.
There has been a tremendous amount of positive buzz surrounding the legal marijuana industry, especially with politician on board to decriminalize the plant. This has helped marijuana stocks witness supreme rallies in recent years.
When the Food and Drug Administration approves the first pharmaceutical drug made from cannabis, it says something. When Corona Beer’s owner makes a $4 billion bet on a marijuana firm called Canopy Growth it says something.
When one marijuana company called Tilray Inc. sees its shares explode from under $60 to over $200 in just three weeks after making its debut in the market, it says something.
When one analyst predicts that legal marijuana could soon become a bigger industry than soda, it says something.
One of the top marijuana analysts, Vivien Azer at Cowen, is also calling for total U.S. cannabis sales to hit $80 billion by 2030!
A survey from Yahoo News and Marist College, has additionally illustrated just how mainstream marijuana has become. Nearly 55 million adults currently use the drug. Let’s face it, we are in a MARIJUANA REVOLUTION!
Over the years, research has yielded results that indicate marijuana may be beneficial in the treatment of many conditions including chronic pain, drug addiction, anxiety, PTSD, neurological disorders, and cancer.
Technical Analysis
We've done our very own chart analysis and see the potential for a move of +100% from here.
Bullish Indicators
Bullish Reversal Cross Imminent
Strong Historical Monthly Support
MCTC could be our next trade idea in the CBD sector to breakout for high double-digit gains.
That being said, we ask that you start your research immediately, and add MCTC to the top of your watchlist.
(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best Regards,
Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report has received TEN thousand dollars compensation to complete this 1 DAY marketing campaign for MCTC .Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.
MCTC Holdings, Inc. (MCTC)
Alert Price: $0.4350
Float: 3.5M
Chart Analysis
Website | Recent News
========================
Members,
it's time for you to get MCTC on your radar.
This low float CBD alert appears ready to breakout on some bullish news that was just released to the public.
MCTC Announces Hemp Extract-Based Alcohol Replacement Technology Test Results: Cannabinoid Levels Undetectable
A few hours ago the Company provided information concerning new test results for its Hemp You Can Feel™ technology, a revolutionary hemp-based infusion designed as a replacement for alcohol in many beverages.
“Our new test results for our Hemp You Can Feel™ infusion technology are very impressive, exceeding even our optimistic expectations,” commented CEO Arman Tabatabaei. “While Hemp You Can Feel™ is based on hemp extracts, certified independent laboratory testing utilizing high-performance liquid chromatography (HPLC) indicated undetectable levels of all hemp extracts and major cannabinoids and an absence of other compounds. We believe the uses for this advanced infusion technology are many, especially as a replacement for alcohol in various beverages.”
The Company recently introduced Hemp You Can Feel™, an infusion technology that provides unparalleled relaxation while allowing the consumer to avoid the negative health effects of alcohol consumption. The technology is based on a manufacturing process that is all natural and relies on no chemical surfactants, stabilizers or additives in order to produce an infusion technology with virtually no detectable taste and excellent food and beverage integration characteristics.
The Company is today announcing separate test results on three new infusions, including the Hemp You Can Feel™ technology in powder form, in a liquid concentrate form and in a premixed nonalcoholic cocktail formulation. In industry standard HPLC-based potency testing conducted by licensed independent laboratories, hemp extract and cannabinoid levels were undetectable for all three preparations. More extensive analysis designed to indicate other similar compounds showed zero presence.
MCTC plans to use this technology as the basis for products it plans to introduce over the coming months. Additionally, the Company plans to license the technology and “white label” manufacture products in its licensed Los Angeles facility, as appropriate.
While additional testing will be required, the Company also believes this unique infusion technology could prove useful as an ultra-low-level cannabidiol (CBD) delivery system for foods and beverages.
Mr. Tabatabaei continued, “Our next step is to create microparticles and nanoparticles of Hemp You Can Feel™ utilizing our patent-pending particle creation process. We think these new microparticle and nanoparticle technologies could prove very useful for advanced food and beverage infusion. We believe this additional area of research is especially topical considering the recent warnings put forth by the U.S. Food and Drug Administration concerning the use of CBD in foods and beverages.”
The Company has recently filed four patents on hemp extract technologies and delivery systems. MCTC is currently working with its patent counsel to protect various aspects of this new technology. Additionally, as previously announced, the Company plans to continue in other areas of delivery systems research, including its programs pertaining to polymeric nanoparticles and nanofibers. The version of Hemp You Can Feel™ being discussed in this release is non-nanoparticle based.
We think the Street is going to react positively to this news, and those who grab up shares early could be handsomely rewarded this week!
This low float alert is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
About MCTC Holdings, Inc.
MCTC Holdings, Inc. (OTC:MCTC) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp industry moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp value chain. The Company plans to actively pursue R&D programs and productization for exotic extract isolation, bioenhancement of hemp extracts and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing hemp sector. The Company is headed and managed by a group of highly experienced hemp and cannabis industry pioneers and entrepreneurs.
More information on the Company can be viewed at www.CannabisGlobalinc.com.
Cutting-Edge Technology
MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (nnw.fm/cK3Bl):
Significantly improving bioavailability
Allowing for ultra-high loading rates
Enhancing customization of cannabinoid combinations
Improved dosing precision
Providing more control in release parameters
MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.
Patents
MCTC has now filed four patents on its cannabinoid delivery technology systems:
The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.
Collaborations
MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).
Recent Developments
MCTC Announces Product Breakthrough - Hemp You Can Feel™ Infusion Technology as Replacement for Alcohol in Beverages
In late November the Comany announced a new class of hemp infusion technology designed to replace alcohol in many beverages. The infusion will be marketed under the Company's Hemp You Can Feel™ brand name and adds to MCTC's growing portfolio of intellectual property, which currently includes four patent pending technologies. As the Company has stated previously, multiple additional patent filings are expected.
"The formulations and delivery vehicles our researchers have developed are nothing short of spectacular," commented Chief Executive Officer, Arman Tabatabaei. "While the technology is based on hemp extracts, levels are many magnitudes lower than are typically seen in the marketplace. In fact, certified laboratory testing utilizing High Performance Liquid Chromatography (HPLC) certified undetectable levels of hemp extracts and cannabinoids. Simply put, we believe this is a revolutionary technology for the marketplace and a legitimate replacement for alcohol in many beverages."
Hemp You Can Feel™, which can be used as the basis for a host of beverage and food formulations provides unparalleled relaxation, while allowing the consumer to avoid the negative health effects of alcohol consumption. The Company is especially proud of the expected label, which is ultra-clean, non-GMO and 100% natural. Manufacturing occurs at room temperature to ensure all the natural enzymes present in the organic portions of the ingredients are preserved. MCTC believes Hemp You Can Feel™ creates an entirely new category of infusion technology for foods and beverages based on natural ingredients.
Hemp You Can Feel™ utilizes no chemical surfactants or stabilizers and requires no high shear processing, sonication, spray drying or other harsh extract manipulations, all of which are common legacy processing technologies. Additionally, the technology contains no artificial colors, dyes, or preservatives and most importantly, there is no detectable hemp taste. The Company is currently capable of producing Hemp You Can Feel™ at high volume in powerized form. A liquid concentrate has also been developed, which is pending final laboratory and formulation testing.
MCTC plans to use this technology as the basis for products it plans to introduce over the coming months. Additionally, the Company plans to license the technology and "white label" produce products at its Los Angeles production facility, as appropriate.
Mr. Tabatabaei continued, "One of the biggest technological challenges was stabilizing the formulation into a substrate. We were fortunate that our researchers were able to work with a major food ingredient manufacturer that provided the exact expertise and associated non-GMO technologies allowing us to complete the last piece of the research puzzle. This development was most certainly an interdisciplinary success based on extensive collaboration between our researchers and others in the food sciences industry."
The Company and its research partner have recently filed four patents on hemp extract technologies and delivery systems. MCTC is currently working with patent counsel to protect various aspects of this new technology. Additionally, as previously announced, the Company plans to continue other areas of hemp extract delivery systems research including its programs pertaining to polymeric nanoparticles and nanofibers and plans additional patent filings relative to expected developments. The technologies being announced today are non-nanoparticle based.
MCTC Expands R&D Program to Include Producing Polymeric Nanoparticles of Valuable, Hard-to-Obtain Cannabinoids
Company’s groundbreaking nanoparticle research has potential to achieve superior effects with reduced amounts of cannabinoids and may lead to new product creation, research avenues
In late November, the Company announced an expanded R&D program designed to produce polymeric nanoparticles of cannabinol (CBN). Expansion of the Company’s R&D program also includes a goal of creating nanoparticles of cannabinoid glycosides. MCTC believes such nanoparticles and nanofibers will hold significant future commercial viability.
CBN is found only in small amounts and mostly results from oxidation of the other cannabinoids in cannabis. Thus, CBN is difficult and expensive to obtain. Nanoparticles of CBN have the potential to allow formulators to use only minuscule amounts of the cannabinoid to achieve the same or superior effects attained using much larger amounts of traditionally prepared CBN. Based on MCTC’s own experience producing cannabidiol (CBD) nanoparticles and nanofibers, the Company’s research team plans to produce CBN nanoparticles with both immediate and controlled-release properties.
“We are continuing our R&D programs based on three primary goals,” commented MCTC CEO Arman Tabatabaei. “First, we plan to continue toward mass production of immediate and controlled-release CBD nanoparticles and, to a lesser extent, CBD nanofibers. Second, we plan to utilize this experience to replicate the process using some of the minor cannabinoids, with CBN selected as the first target. Lastly, we are focusing all of our research toward protecting the intellectual property we develop. Thus far, we have filed four patents, with one additional application in progress. We are likely to file several more patent applications over the coming months as our cannabinoid R&D programs progress.”
MCTC has also added the creation of nanoparticles of cannabinoid glycosides to its research program.
One of the aims of the CBN, minor cannabinoid and glycosides research program is to develop nanoparticles of these cannabinoids for inclusion in coaxial particles of other cannabinoids. For example, several studies indicate that CBN may counteract some of the negative effects of other cannabinoids; thus, the creation of coaxial particles containing both CBN and other cannabinoids, especially psychoactive cannabinoids, could lead to new avenues of research and possibility to commercially viable products.
The polymer-based nanoparticles being developed by MCTC significantly differ from the simple oil-in-water nanoemulsions being marketed as interim solutions for the food and beverage industry. The polymer-based particles the Company is developing will allow for significant loading of active ingredients and unparalleled flexibility in creating custom cannabinoid combinations with unique performance characteristics. MCTC believes polymeric nanoparticles will be an important technology area for the cannabinoid formulation marketplace. The Company plans multiple additional patent filings relative to these technologies.
Market Outlook:
Brightfield Group, a leading market and consumer intelligence firm for the legal CBD and cannabis industries, reported significant expected acceleration in growth for the CBD market, resulting in a 706% year-over-year CBD product sales jump in the US in 2019 to around $5 billion in total sales, with sales expected to reach $23.7 billion by 2023. This suggests the overall CBD-based products market is set to grow by a stunning 107% CAGR over coming years.
Zenith Global, a leading global food and drink consulting firm, projects that the US market for cannabis, CBD and Hemp infused drinks will grow to over $1.4 Billion by 2024, an almost fifteen times (15x) increase from 2018 sales of just $89 million.
According to the Marijuana Business Factbook, retail sales of medical and recreational cannabis in the United States are on pace to eclipse $12 billion by the end of this year. This would be an increase of roughly 35% over 2018.
Retail sales could rise as high as $30 billion by 2023!
It was a banner year in 2018 with investors pouring an amazing $10 billion into cannabis in North America.
There has been a tremendous amount of positive buzz surrounding the legal marijuana industry, especially with politician on board to decriminalize the plant. This has helped marijuana stocks witness supreme rallies in recent years.
When the Food and Drug Administration approves the first pharmaceutical drug made from cannabis, it says something. When Corona Beer’s owner makes a $4 billion bet on a marijuana firm called Canopy Growth it says something.
When one marijuana company called Tilray Inc. sees its shares explode from under $60 to over $200 in just three weeks after making its debut in the market, it says something.
When one analyst predicts that legal marijuana could soon become a bigger industry than soda, it says something.
One of the top marijuana analysts, Vivien Azer at Cowen, is also calling for total U.S. cannabis sales to hit $80 billion by 2030!
A survey from Yahoo News and Marist College, has additionally illustrated just how mainstream marijuana has become. Nearly 55 million adults currently use the drug. Let’s face it, we are in a MARIJUANA REVOLUTION!
Over the years, research has yielded results that indicate marijuana may be beneficial in the treatment of many conditions including chronic pain, drug addiction, anxiety, PTSD, neurological disorders, and cancer.
Technical Analysis
We've done our very own chart analysis and see the potential for a move of +100% from here.
Bullish Indicators
Bullish Reversal Cross Imminent
Strong Historical Monthly Support
MCTC could be our next trade idea in the CBD sector to breakout for high double-digit gains.
That being said, we ask that you start your research immediately, and add MCTC to the top of your watchlist.
(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best Regards,
Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report has received TEN thousand dollars compensation to complete this 1 DAY marketing campaign for MCTC .Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.